These 5 “Magic Formula” Biotech Stocks Are Guru Approved
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
High-risk stocks have soared since the March selloff. As the author of today’s article observes, “In essence, most investors on Wall Street are positioning for…
The two small-cap biotech stocks highlighted in today’s article appear poised to dominate this year and beyond. Why? As the author explains, “Both companies are…
The stock market could be in for an especially volatile time this week and into July – and while the acceleration in new coronavirus cases…
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…
In the cancer treatment space, today’s article highlights two small-cap biotech names to consider this month based on their attractive prices and potential to “take…
Recently, many bankrupt and near-bankrupt companies have experienced large price increases. What’s behind this seemingly very irrational trading behavior? The author of today’s article outlines…
“The challenge for investors who are looking to cash in on the hype surrounding a Covid-19 vaccine is placing their bets on the right horse,”…
“Shares of smaller companies are often volatile, but for investors willing to ride out the tug-of-war between greed and fear, these companies have strong growth…